Author

Mohd Zainuddin

Observed names: Mohd, Zainuddin, Mohd. Zainuddin, Z. Mohd, Zainuddin Mohd

OpenAlex ID: A5111184517

Novel dual LSD1/HDAC6 inhibitors for the treatment of multiple myeloma

2020 · M Naveen Sadhu, Dhanalakshmi Sivanandhan, et al. · Bioorganic & Medicinal Chemistry Letters · 41

A validated LC‐MS/MS assay for simultaneous quantification of methotrexate and tofacitinib in rat plasma: application to a pharmacokinetic study

2014 · Kuldeep Sharma, Kalpeshkumar Giri, et al. · Biomedical Chromatography · 39

Development and validation of a highly sensitive method for the determination of abiraterone in rat and human plasma by LC‐MS/MS‐ESI: application to a pharmacokinetic study

2011 · Sandip Gurav, Ravindra Punde, et al. · Biomedical Chromatography · 36

Validated RP‐HPLC/UV method for the quantitation of abiraterone in rat plasma and its application to a pharmacokinetic study in rats

2012 · S. Vijay Kumar, G. Rudresha, et al. · Biomedical Chromatography · 29

Development and validation of a RP‐HPLC method for the quantitation of tofacitinib in rat plasma and its application to a pharmacokinetic study

2015 · Vijay Kumar S, Vinay Dhiman, et al. · Biomedical Chromatography · 28

Novel KV7 ion channel openers for the treatment of epilepsy and implications for detrusor tissue contraction

2018 · Mark A. Seefeld, Hong Lin, et al. · Bioorganic & Medicinal Chemistry Letters · 27

Validated HPLC‐MS/MS method for quantitation of AMG 510, a KRAS G12C inhibitor, in mouse plasma and its application to a pharmacokinetic study in mice

2020 · Naveena Madhyastha, Swapan Kumar Samantha, et al. · Biomedical Chromatography · 21

Development and validation of a novel method for simultaneous quantification of enzalutamide, darolutamide and their active metabolites in mice dried blood spots using LC-MS/MS: Application to pharmacokinetic study in mice

2018 · Neeraj Kumar Saini, Suresh P Sulochana, et al. · ADMET & DMPK · 20

PDF

LC–MS/MS-ESI method for simultaneous quantification of darolutamide and its active metabolite, ORM-15341 in mice plasma and its application to a pharmacokinetic study

2017 · Sreekanth Dittakavi, Pavan Kumar V.S.P. Nagasuri, et al. · Journal of Pharmaceutical and Biomedical Analysis · 16

Determination of epacadostat, a novel IDO1 inhibitor in mouse plasma by LC–MS/MS and its application to a pharmacokinetic study in mice

2016 · Vinay Dhiman, Kalpesh Kumar Giri, et al. · Biomedical Chromatography · 16

Validated HPLC‐UV method for simultaneous quantification of phosphatidylinositol 3‐kinase inhibitors, copanlisib, duvelisib and idelalisib, in rat plasma: Application to a pharmacokinetic study in rats

2020 · Anup Siddesh, Dhurvu Sriram, et al. · Biomedical Chromatography · 14

Novel Dual Inhibitor of LSD1-HDAC6/8 for Treatment of Cancer

2020 · Dhanalakshmi S, Sridharan Rajagopal, et al. · Blood · 13

Validation of an LC-ESI–MS/MS method for the determination of apalutamide, a novel non-steroidal anti-androgen in mice plasma and its application to a pharmacokinetic study in mice

2018 · Gurulingappa Hallur, Buchi Reddy Purra, et al. · Journal of Pharmaceutical and Biomedical Analysis · 13

Determination of ulixertinib in mice plasma by LC–MS/MS and its application to a pharmacokinetic study in mice

2016 · Rajinish Kumar, P.S. Suresh, et al. · Journal of Pharmaceutical and Biomedical Analysis · 13

Determination of Tofacitinib in Mice Whole Blood on Dried Blood Spots Using LC–ESI–MS/MS: Application to Pharmacokinetic Study in Mice

2018 · Abhishek Dixit, Sadanand Rangnathrao Mallurwar, et al. · Drug Research · 12

Abstract 1756: JBI-802, novel dual inhibitor of LSD1-HDAC6 for treatment of cancer

2020 · Dhanalakshmi Sivanandhan, Sridharan Rajagopal, et al. · Cancer Research · 11

Novel, small molecule inhibitors of PD-1/PD-L1 pathway.

2022 · Luca Rastelli, Sridharan Rajagopal, et al. · Journal of Clinical Oncology · 10

LC-ESI–MS/MS determination of defactinib, a novel FAK inhibitor in mice plasma and its application to a pharmacokinetic study in mice

2017 · Gurulingappa Hallur, Natarajan Tamizharasan, et al. · Journal of Pharmaceutical and Biomedical Analysis · 10

Validation of an LC–MS/MS method for simultaneous detection of four HDAC inhibitors – belinostat, panobinostat, rocilinostat and vorinostat in mouse plasma and its application to a mouse pharmacokinetic study

2016 · Kalpesh Kumar Giri, P. S. Suresh, et al. · Biomedical Chromatography · 10

A novel dried blood spot LC–MS/MS method for the quantification of apalutamide in mouse whole blood: Application to pharmacokinetic study in mice

2018 · Neeraj Kumar Saini, Suresh P. Sulochana, et al. · Biomedical Chromatography · 9

Prediction of Human Pharmacokinetics of Ulixertinib, a Novel ERK1/2 Inhibitor from Mice, Rats, and Dogs Pharmacokinetics

2018 · Ponnayyan Sulochana Suresh, Ravi Kumar Jairam, et al. · European Journal of Drug Metabolism and Pharmacokinetics · 9

Validated LC-MS/MS Method for Simultaneous Quantitation of Three PI3K Inhibitors, Copanlisib, Duvelisib and Idelalisib in Mouse Plasma: Application to a Pharmacokinetic Study in Mice

2021 · Bhavesh Babulal Gabani, Sreekanth Dittakavi, et al. · Analytical Chemistry Letters · 8

PDF

Modulating inhibitory response control through potentiation of GluN2D subunit-containing NMDA receptors

2020 · Patrick M. Callahan, Alvin V. Terry, et al. · Neuropharmacology · 8

PDF

Validated LC–MS/MS method for quantitation of a selective JAK1 inhibitor, filgotinib in rat plasma, and its application to a pharmacokinetic study in rats

2020 · Abhishek Dixit, Vinay Kiran, et al. · Biomedical Chromatography · 8

Validated HPLC method for simultaneous quantification of mutant IDH1/2 inhibitors (enasidenib, ivosidenib and vorasidenib) in mouse plasma: Application to a pharmacokinetic study

2019 · Ashok Zakkula, Sreekanth Dittakavi, et al. · Biomedical Chromatography · 8

Works count: 61

Citation count: 493

H-index: 13

I10-index: 19